BioSig Technologies, Inc. STEX Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s deferred tax assets, valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s deferred tax assets, valuation allowance?
- BioSig Technologies, Inc. (STEX) reported deferred tax assets, valuation allowance of $53.69M in Q4 2025.
- How has BioSig Technologies, Inc.'s deferred tax assets, valuation allowance changed year-over-year?
- BioSig Technologies, Inc.'s deferred tax assets, valuation allowance increased by 14.3% year-over-year, from $46.98M to $53.69M.
- What is the long-term trend for BioSig Technologies, Inc.'s deferred tax assets, valuation allowance?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s deferred tax assets, valuation allowance has grown at a 16.8% compound annual growth rate (CAGR), from $24.7M to $53.69M.